Blockage of HDAC6 also ameliorated PAH induced in the sugen/hypoxia and MCT rat model as illustrated by reducing abnormal high right-ventricle systolic and pulmonary pressure, as well as right-ventricle and vascular remodeling [130]. The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.